Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
巨噬细胞、细胞间通讯、糖尿病缺血性损伤和 RAGE/DIAPH1 信号轴
基本信息
- 批准号:10407554
- 负责人:
- 金额:$ 248.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdvanced Glycosylation End ProductsAdverse effectsAffectAnterior Descending Coronary ArteryAtherosclerosisBedsBindingBiological AssayBiologyBiophysicsBiostatistics CoreBlood flowBone Marrow TransplantationCalciumCardiac MyocytesCardiovascular systemCell CommunicationCell Death Signaling ProcessCell TherapyCellsComplexComplications of Diabetes MellitusCuesCytoplasmic TailDevelopmentDiabetes MellitusDiabetic mouseEndoplasmic ReticulumEndothelial CellsFluorescenceGenerationsGenesHMGB1 ProteinHeartHyperglycemiaInfiltrationInflammationInflammation MediatorsInflammatory ResponseInjuryInsulin-Dependent Diabetes MellitusIschemiaLeftLeukocyte L1 Antigen ComplexLigandsLigationLimb structureLoxP-flanked alleleMeasuresMediatingMetabolic dysfunctionMitochondriaModelingMolecularMolecular Biology TechniquesMusMyelogenousMyocardial InfarctionNMR SpectroscopyNon-Insulin-Dependent Diabetes MellitusOrganOrgan failureOxidative StressOxidesPathologyPeripheralPeripheral arterial diseasePharmacologyPharmacotherapyPhysiologicalProcessPropertyProteinsProteomicsRNA InterferenceRecoveryRegulationReperfusion InjuryReperfusion TherapySignal TransductionSiteSkeletal MuscleStressStructureSystemTestingTherapeuticTissuesWorkangiogenesisantagonistbasedata managementdiabeticfemoral arteryin vivoinnovationirradiationischemic injurylimb ischemiamacrophagemitochondrial dysfunctionmonocytemouse modelmutantnon-diabeticnovelnovel therapeutic interventionnovel therapeuticsprogramsreceptor for advanced glycation endproductsreceptor functionrecruitrepairedresponsesmall moleculestructural biologytissue repairtranscriptome sequencing
项目摘要
Project Summary: OVERALL
Ischemia, a complication of diabetic cardiovascular (CVD) and peripheral arterial disease (PAD), is accompanied
by the recruitment, infiltration and activation of monocytes/macrophages (MΦs), into affected tissues. In
diabetes, MΦ properties are perturbed and repair is significantly mitigated, leading to organ failure. The
microenvironments in the heart vs. the skeletal muscle display unique responses to ischemia, but the
mechanisms are not fully understood. The ligands of the receptor for advanced glycation endproducts (RAGE),
such as nonenzymatically glycated and oxidized advanced glycation endproducts; S100/calgranulins and high
mobility group box 1, which accumulate in non-diabetic and diabetic CVD and PAD tissue, and RAGE itself,
contribute to MΦ and niche-specific responses to ischemia. Mice globally devoid of Ager (the gene encoding
RAGE) or devoid of myeloid Ager (lethal irradiation/bone marrow transplantation) are protected from the adverse
effects of ligation of the left anterior descending coronary artery and the femoral artery, models for myocardial
infarction (MI) and hind limb ischemia (HLI), respectively. In MI and HLI models, Ager deletion is accompanied
by a marked reduction in tissue MΦ content and reduced expression of inflammatory mediators. Surprisingly, in
HLI, deletion of Ager is accompanied by increased MΦ content and expression of inflammatory mediators in the
skeletal muscle. Yet, in both cases, Ager deletion augured repair. Our discovery that the cytoplasmic domain of
RAGE interaction with the formin, DIAPH1, mediates signal transduction, generation of oxidative stress and
mitochondrial dysfunction (on account of our novel discovery that DIAPH1 binds to Mitofusin2 (MFN2) in
ischemic tissue MΦs, cardiomyocytes and endothelial cells), may hold the key to these RAGE-dependent
findings. The three Projects of this Program will use novel mouse models, state-of-the-art molecular biology
techniques, novel small molecule antagonists of RAGE-DIAPH1 interaction, NMR spectroscopy and in-cell
fluorescence assays to test the hypothesis that RAGE/DIAPH1 contributes to MΦ cell-intrinsic and MΦ-
cardiomyocyte cross talk in MI and to and MΦ-endothelial cell cross talk in HLI, thereby amplifying tissue
damage. We posit that RAGE-DIAPH1 and DIAPH1-MFN2 interactions control MΦ inflammation and that
pharmacological blockade of RAGE-DIAPH1-MFN2 interaction and/or administration of monocytes/MΦs devoid
of Ager or Diaph1 will facilitate the transition from pro-injury to adaptive MΦ inflammation and, thereby, hasten
tissue repair in the diabetic heart and peripheral arterial systems. The meticulous integration of in vivo biology
and molecular mechanisms studies (Projects 1 and 2) with structural biology (Project 3) assures the innovation,
significance and ultimate relevance of this work for the development of novel therapeutic strategies for diabetes
and ischemia.
项目总结:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANN MARIE SCHMIDT其他文献
ANN MARIE SCHMIDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANN MARIE SCHMIDT', 18)}}的其他基金
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
巨噬细胞、细胞间通讯、糖尿病缺血性损伤和 RAGE/DIAPH1 信号轴
- 批准号:
10191018 - 财政年份:2019
- 资助金额:
$ 248.03万 - 项目类别:
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
项目2:糖尿病、RAGE/DIAPH1 和后肢缺血
- 批准号:
10191022 - 财政年份:2019
- 资助金额:
$ 248.03万 - 项目类别:
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
项目2:糖尿病、RAGE/DIAPH1 和后肢缺血
- 批准号:
10407558 - 财政年份:2019
- 资助金额:
$ 248.03万 - 项目类别:
Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis
巨噬细胞、细胞间通讯、糖尿病缺血性损伤和 RAGE/DIAPH1 信号轴
- 批准号:
10642704 - 财政年份:2019
- 资助金额:
$ 248.03万 - 项目类别:
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
项目2:糖尿病、RAGE/DIAPH1 和后肢缺血
- 批准号:
10642712 - 财政年份:2019
- 资助金额:
$ 248.03万 - 项目类别:
RAGE, DIAPH1 and IRF7 and Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Disease
动脉粥样硬化和心脏代谢疾病中的 RAGE、DIAPH1 和 IRF7 以及巨噬细胞功能障碍
- 批准号:
10424906 - 财政年份:2017
- 资助金额:
$ 248.03万 - 项目类别:
相似海外基金
ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
- 批准号:
3776700 - 财政年份:
- 资助金额:
$ 248.03万 - 项目类别:
ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
- 批准号:
3840306 - 财政年份:
- 资助金额:
$ 248.03万 - 项目类别:
ADVANCED GLYCOSYLATION END PRODUCTS AND EFFECT OF MESANGIAL CELLS
高级糖基化最终产物和对系膜细胞的影响
- 批准号:
3855332 - 财政年份:
- 资助金额:
$ 248.03万 - 项目类别:
GLOMERULAR EFFECTS OF ADVANCED GLYCOSYLATION END PRODUCTS
高级糖基化最终产物对肾小球的影响
- 批准号:
5202002 - 财政年份:
- 资助金额:
$ 248.03万 - 项目类别:
GLOMERULAR EFFECTS OF ADVANCED GLYCOSYLATION END PRODUCTS
高级糖基化最终产物对肾小球的影响
- 批准号:
3754540 - 财政年份:
- 资助金额:
$ 248.03万 - 项目类别: